C8-substituted purine nucleotide analogs
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 9, 2003
Grant Date -
N/A
app pub date -
Jun 9, 2000
filing date -
Jun 9, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
C8-substituted purine nucleotide analogs, such as ATP analogs, and their use is described, including their use as inhibitors of NTPDases and thereby as tools to modulate the conversion of nucleotides into nucleoside derivatives, and thus modulate the levels of these compounds. Such modulation further provides for the modulation of the activity and function of many processes which are affected by these compounds.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully